期刊文献+

肥胖与慢性肾脏病患者冠状动脉疾病的关系 被引量:2

下载PDF
导出
摘要 目的:了解肥胖对慢性肾脏病(CKD)患者发生冠状动脉疾病(CAD)的影响,并探索体重指数(BMI)、腰围、腰臀比对CAD的预测价值。方法:选取102例非透析CKD患者,分别以BMI、腰围、腰臀比作为肥胖的判定指标,将患者分为肥胖组与非肥胖组,比较各组CAD的患病率。以多因素Logistic回归分析各项肥胖评价指标与CAD的关系。结果:(1)CKD患者的肥胖以中心性肥胖较多见。(2)腰围超标组患者CAD的患病率为39.5%,高于腰围正常组的15.3%,差异具有统计学意义(P<0.01)。以BMI、腰臀比为标准划分的肥胖组与非肥胖组患者CAD患病率差异无统计学意义。(3)多因素Logistic回归分析显示,腰围是CKD患者发生冠状动脉疾病的危险因素,OR值为2.643。结论:肥胖是非透析CKD患者发生CAD的危险因素,腰围可以作为CKD患者冠状动脉疾病的直接预测因素。
作者 陈燕 孙伟
出处 《中国中西医结合肾病杂志》 2010年第9期805-807,共3页 Chinese Journal of Integrated Traditional and Western Nephrology
基金 江苏省中医药领军人才培养基金资助项目
  • 相关文献

参考文献11

  • 1郑法雷.面对慢性肾病患者心血管病的严重挑战——“新”危险因素与防治对策[J].中国中西医结合肾病杂志,2005,6(7):373-376. 被引量:5
  • 2侯凡凡,马志刚,梅长林,戎殳,黄颂敏,刘先蓉,袁伟杰,郭云珊,王莉,何强,王秀玲,桑晓红,栗霄立.中国五省市自治区慢性肾脏病患者心血管疾病的患病率调查[J].中华医学杂志,2005,85(7):458-463. 被引量:183
  • 3Murphy NF,MacIntyre K,Stewart S,et al.Long-term cardiovascular consequences of obesity:20-year follow-up of more than 15000 middle-aged men and women(the Renfrew-Paisley study).Eur Heart J,2006,27(1):96-106.
  • 4Empana JP,Ducimetiere P,Charles MA,et al.Sagittal abdominal diameter and risk of sudden death in asymptomatic Middleaged men:the Paris Prospective Study I.Circulation,2004,110(18):2781-2785.
  • 5Kalantar-Zadeh K,Kopple JD,Kilpatrick RD,et al.Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis patients.Am J Kidney Dis,2005,46(3):489-500.
  • 6Madero M,Sarnak MJ,Wang X,et al.Body mass index and mortality in CKD.Am J Kidney Dis,2007,50(3):404-411.
  • 7Qureshi AR,Alvestrand A,Divino-Filho JC,et al.Inflammation,malnutrition,and cardiac disease as predictors of mortality in hemodialysis patients.J Am Soc Nephrol,2002,13(Suppl 1):S28-S36.
  • 8Araújo IC,Kamimura MA,Draibe SA,et al.Nutritional parameters and mortality in incident hemodialysis patients.J Ren Nutr,2006,16(1):27-35.
  • 9Sanches FM,Avesani CM,Kamimura MA,et al.Waist circumference and visceral fat in CKD:a cross-sectional study.Am J Kidney Dis,2008,52(1):66-73.
  • 10Postorino M,Marino C,Tripepi G,et al.Abdominal obesity and all-cause and cardiovascular mortality in end-Stage renal disease.J Am Coll Cardiol,2009,53(15):1265-1272.

二级参考文献46

  • 1侯凡凡.慢性肾脏病的心血管并发症[J].中华心血管病杂志,2004,32:16-16.
  • 2何长民 张训 见:何长民 张训主编.前言[A].见:何长民,张训主编.肾脏替代治疗学[C].上海:上海科学技术文献出版社,1999.2..
  • 3Locatelli F, Pozzoni P, Tentori F, et al. Epidemiology of cardiovascular risk in patients with chronic kidney disease. Nephrol Dial Transplant, 2003,18 Suppl 7:2-9.
  • 4Muntner P, He J, Hamm L, et al. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol, 2002,13:745-753.
  • 5Manjunath G, Tighiouart H, Ibrahim H, et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol, 2003,41:47-55.
  • 6Foley RN, Parfrey PS, Harnett JD, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int, 1995,47:186-192.
  • 7Sarnak MJ, Levey AS, Schoolwerth AC,et al. Kidney disease as a risk factor for development of cardiovascular disease. A statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation, 2003,108:2154-2169.
  • 8Foley RN, Herzog CA, Collins AJ. Smoking and cardiovascular outcomes in dialysis patients: the United States Renal Data System Wave 2 Study. Kidney Int, 2003,63:1462-1467.
  • 9Wong JS, Rort FK, Hulbert-Shearon TE, et al. Survival advantage in Asian American end-stage renal disease patients. Kidney Int, 1999,55:2515-2523.
  • 10Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis, 1998,32:s112-s119.

共引文献186

同被引文献12

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部